Lipitor In The Prevention Of Stroke, For Patients Who Have Had A Previous Stroke (SPARCL)

Pfizer logo

Pfizer

Status and phase

Completed
Phase 4

Conditions

Cardiovascular Disease

Treatments

Drug: atorvastatin

Study type

Interventional

Funder types

Industry

Identifiers

NCT00147602
A2581138
0981-342

Details and patient eligibility

About

To determine whether Lipitor reduces stroke, compared to placebo in patients who have had a previous stroke or transient ischemic attack.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Previous stroke or TIA

Exclusion criteria

coronary heart disease

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

Trial contacts and locations

130

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems